During the past decade, Hospital General Mateu Orfila conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Mateu Orfila" #1 collaborator was "REDGERM" with 1 trials as a collaborator and "Sociedad Española de Cirugía de la Obesidad" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Mateu Orfila" are "Perioperative Care" (2 trials), "Postoperative Complications" (2 trials), "Acute Appendicitis" (1 trials), "Bariatric Surgery Candidate" (1 trials) and "Colorectal Surgery" (1 trials). Many other conditions were trialed in "Hospital General Mateu Orfila" in a lesser frequency.

Most popular intervention types in "Hospital General Mateu Orfila" are "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Colorectal Surgery" (1 trials) and "Modified RIPASA score" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Mateu Orfila" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital General Mateu Orfila". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital General Mateu Orfila, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Mateu Orfila, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".